Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
  • The Scientist
    Solid OS data for THLD Th-302 in panc ca. OS+2.5 mos in highest dose. Tarceva approved with 0.4 mos. Discontinuation rate lowest for highest
    9/17/12
    Reply (2)
    • The Scientist: TH-302 dose. High prob FDA approval. Huge unmet need. Gemzar initial approval based on 126 pts (Gemzar insert). Adcetris approv 102/58 pts
      9/17/12
    • The Scientist: Huge improvement PFS/OS over current SOC. Good safety profile-fewer discontinuations with highest dose.
      9/17/12